![]() ![]() Approved under accelerated approval based on the change from baseline in anti-FXa activity in healthy volunteers.Rivaroxaban >10 mg or dose unknown (5 mg or dose unknown (Apixaban >5 mg or dose unknown (≥8 hr from last dose).Rivaroxaban >10 mg or dose unknown (≥8 hr from last dose).Apixaban dose ≤5 mg (any timing from last dose). ![]() Rivaroxaban dose ≤10 mg (any timing from last dose).Follow-on IV infusion: 8 mg/min IV for up to 120 minĭose based on rivaroxaban or apixaban dose.Initial IV bolus: 800 mg IV target infusion rate of 30 mg/min.Follow-on IV infusion: 4 mg/min IV for up to 120 min.Initial IV bolus: 400 mg IV target infusion rate of 30 mg/min.Safety and efficacy of an additional dose has not been established Low or high dose regimens There are 2 dosage regimens (low dose or high dose) to choose from Indicated for patients treated with rivaroxaban and apixaban, when reversal of anticoagulation is needed because of life-threatening or uncontrolled bleeding ![]() Dosage Forms & Strengths injection, lyophilized powder for reconstitution ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |